Akelos, Inc. — Form D
Akelos, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-16. $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-16
- Form: D
- Accession: 0001760186-26-000005
- Industry: Biotechnology
- Exemptions: 06c
- Amount sold: $1.5M
- Minimum investment: $14K
- Investors: 81
- Date of first sale: 2026-03-09
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-576640
Issuer
- Name: Akelos, Inc.
- CIK: 0001760186
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 215 EAST 68TH STREET, SUITE 26B, NEW YORK, NY, 10065
- Phone: 212-953-1544
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Steven Fox | Director | New York, NY |
| Steven Fox | Executive Officer | New York, NY |
Other filings by this issuer (3)
More